Apple has opened a large-scale research study into how people actually use artificial intelligence for health questions, launching a dedicated iPhone app built with clinical AI company OpenEvidence. The Apple Health AI Usage Study, announced on Sunday, will recruit up to 200,000 participants across the United States.

Participants will use the study app to ask everyday health questions — the same kind of questions millions of people already type into chatbots such as ChatGPT and Claude — and receive answers grounded in peer-reviewed medical literature, with linked citations they can check for themselves. Apple says the study will measure trust, comprehension, response quality and the everyday health actions people take after reading an answer.

A chatbot built on doctors' sources

The answers come from OpenEvidence, a clinical AI platform widely used by healthcare professionals. The company generates responses from medical information in established sources including The New England Journal of Medicine, the Journal of the American Medical Association and Nature. Apple designed the research experience around that technology, while OpenEvidence supplies the underlying AI.

Participants can rate the answers they receive, submit written feedback and answer monthly surveys. They can also choose to share HealthKit data, such as resting heart rate, activity, sleep and lab results, so researchers can see how health AI fits into people's real routines. Apple said it picked OpenEvidence for its high-quality medical sources, strong privacy controls and advanced search models.

Privacy rules — and what the app will not do

Apple stressed the guardrails around the study. Data is anonymised before it is sent to a secure third-party cloud, it will not be used to train AI models, and OpenEvidence deletes each question and response within 24 hours. The study app is not meant to diagnose or treat any condition, and it does not replace the advice of a medical professional.

Joining the study is limited to adults aged 21 and older in the United States, using an iPhone 15 Pro or later running iOS 26 or later with Apple Intelligence switched on. The study is expected to run for more than 12 months, with participants able to stay enrolled for up to a year.

Why Apple is studying, not shipping

The study was unveiled at the HLTH26 health conference in Las Vegas, where Sumbul Desai, Apple's vice president of health, explained that the company wants to understand how consumers interact with conversational health AI before building it into its products. Apple has not said whether the findings will lead to AI-generated answers in the Health app or Siri — for now, this is research, not a product launch.

The move also deepens Apple's long push into health, from the Apple Watch's heart and sleep tracking to the Health app's lab results. OpenEvidence, meanwhile, has become one of the hottest names in clinical AI: it raised $250 million at a $15 billion valuation in September. If the study shows people can understand and act on AI health answers safely, it could shape how Apple — and the wider industry — brings conversational AI into everyday healthcare.

By Hamza Faisal